ドナー用血液成分の市場規模および予測 2021～2031年、世界および地域シェア、動向、成長機会分析レポート：血液成分、適応症、用途、年齢層、エンドユーザー、地域

弊社の最新調査レポート「ドナー血液成分市場の2031年までの予測 - 世界分析：血液成分別、適応症別、用途別、年齢層別、地域別」によると、市場は2024年の100億8,000万米ドルから成長し、2031年には146億4,000万米ドルに達すると予測され、2025年から2031年にかけてCAGR 5.7％を記録する見込みです。がんや免疫抑制性疾患の有病率の上昇、ドナー意識の高まりが、ドナー血液成分市場規模の拡大に寄与しています。しかし、自発的な献血が安定しないことがドナー血液成分市場の成長を妨げています。さらに、血漿由来の治療に対する需要の高まりは、今後数年間に新たなドナー血液成分市場動向をもたらすと予想されます。

ドナー血液成分市場は、手術、外傷、がん治療、慢性疾患における安全な輸血の必要性の高まりに牽引され、ヘルスケア産業の顕著なセグメントの一つです。ドナー血液成分には、赤血球（RBC）、血漿、血小板、凍結沈殿物が含まれます。ドナー血液成分市場の成長は、世界の意識の高まり、人口の高齢化、収集・保存技術の進歩によって推進されています。しかし、特定の地域における自発的な献血率の低さ、規制上の問題、物流上の制約といった問題は依然として残っています。アフェレシスや病原体減少システムなどの新技術は、製品の安全性と効率を向上させています。さらに、定期的で自発的な献血を増やすための政府やNGOの取り組みが、献血者数を増やしています。この市場は、特に進化するヘルスケアシステムにおいて、大きな可能性を秘めています。

ドナー血液成分市場分析

新興市場の需要が将来の市場機会をもたらす

新興経済圏、特に東南アジア、ラテンアメリカ、アフリカの一部地域は、ドナー血液成分市場に大きな成長機会を提供しています。これらの経済圏のヘルスケア・インフラが成長するにつれて、献血施設への投資が戦略的必須事項として浮上しています。アルゼンチン、ブラジル、メキシコでは、自発的な献血プログラムが大きな支持を得ています：ラテンアメリカでは、2023年には2020年比15.5%増の920万単位以上の献血が行われ、その56.8%はモバイルドライブやオンラインキャンペーンによる自発的なものでした。この成長は、各国の血液システムに影響を与えた啓発キャンペーンや官民連携の協調を表しています。同様に、例えばインドネシアでは、Asian Agriのような企業献血者が地域献血週間を開始し、地方の州から数百単位を集めました。2024年6月には、414人のドナーが参加し、3つの州から287単位が集まり、在庫と意識向上に貢献しました。このような民間セクターの協力は、地域社会の信頼とドナーの参加を高めます。

WHOによると、開発途上国では血液製剤の需要が毎年5％増加すると予測されています。この需要に対応するため、インドネシアの新しい血漿分画工場やアフリカでの移動採血の増加など、各国はインフラの近代化に力を入れています。アフェレシス機器、NAT検査、自動化処理といった形で技術利用が進み、安全性と社会的信用が高まっています。

増大する医療需要、自発的献血の増加、デジタル支援活動、規制改革が融合することで、新興市場はドナー血液サービスの成長に適しています。このようなシステムの開発は、臨床ニーズの増加に対応するだけでなく、世界のドナー血液成分市場の長期的な持続可能性を促進します。

ドナー血液成分市場のセグメンテーション分析

ドナー血液成分市場の分析に貢献した主なセグメントは、血液成分、適応症、用途、年齢層、性別、エンドユーザーです。

血液成分別では、ドナー血液成分市場は赤血球、白血球、血小板、血漿、その他に区分されます。2024年には赤血球セグメントが市場で最大のシェアを占めています。

適応症別では、ドナー血液成分市場は免疫抑制と腫瘍に二分されます。2024年には免疫抑制分野が市場を独占しました。

用途別では、ドナー血液成分市場は貧血管理、血小板減少症治療、凝固障害補正、化学療法中の支持療法、手術、その他に区分されます。貧血管理分野は2024年に市場で最大のシェアを占めました。

年齢層別では、ドナー血液成分市場は成人と小児に二分されます。2024年には成人セグメントが市場を独占しました。

エンドユーザー別では、ドナー血液成分市場は病院、腫瘍センター、移植センター、外来手術センター、その他に分類されます。2024年の市場は病院部門が最大のシェアを占めています。

ドナー血液成分市場競合情勢と主な発展

Roswell Park Comprehensive Cancer Center、Policlinico of Milan、Vitalant、MD Anderson Cancer Center、The Johns Hopkins Hospital、The Royal Marsden、Gustave Roussy、Peter MacCallum Cancer Centre、Tata Memorial Hospital、Memorial Sloan Kettering Cancer Centerなどが、ドナー血液成分市場で事業を展開する主要企業です。

世界保健機関（WHO）、米国形成外科学会、保健資源サービス庁、米国がん協会、白血病リンパ腫協会、カナダ保健省、国際がん研究機関（IARC）、連邦統計局（Destatis）、マクミランがんサポートデータ、National Health Commission（NHC）、Indian Council of Medical Research-National Centre for Disease Informatics and Research（ICMR-NCDIR）、Australian Institute of Health and Welfare、Australian Red Cross Lifeblood、GLOBOCANなどは、ドナー血液成分市場レポートを作成する際に参照した一次調査と二次調査の情報です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

• アナリスト市場の展望

第3章 調査手法

• 2次調査
• 1次調査
  • 仮説の策定
  • マクロ経済要因分析
  • ファンデーション数値の開発
  • データの三角測量
  • 国レベルのデータ
• 仮定と限界

第4章 ドナー血液成分市場情勢

• PEST分析
• 血液成分の単位当たり平均販売価格（米国）、2024年
• 主要5疾患の世界有病率、2024年

第5章 ドナー血液成分市場：主要市場力学

• ドナー血液成分市場- 主な市場力学
• 市場促進要因
  • がんと免疫抑制性疾患の有病率の上昇
  • ドナーに対する意識の高まり
• 市場抑制要因
  • 一貫性のない自発的献血
• 市場機会
  • 新興市場の需要
• 今後の動向
  • 血漿由来治療に対する需要の高まり
• 促進要因と抑制要因の影響

第6章 ドナー血液成分市場：世界市場分析

• ドナー血液成分市場の収益、2021～2031年
• ドナー血液成分市場の予測分析

第7章 ドナー血液成分市場分析 - 血液成分別

• 赤血球
• 白血球
• 血小板
• 血漿
• その他

第8章 ドナー血液成分市場分析 - 適応症別

• 免疫抑制
• 腫瘍

第9章 ドナー血液成分市場分析 - 用途別

• 貧血管理
• 血小板減少治療
• 凝固障害補正
• 化学療法中の支持療法
• 外科手術
• その他

第10章 ドナー血液成分市場分析 - 年齢層別

• 成人
• 小児

第11章 ドナー血液成分の市場分析 - エンドユーザー別

• 病院
• 腫瘍センター
• 移植センター
• 外来手術センター
• その他

第12章 ドナー血液成分市場 - 地域別分析

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • 欧州のその他諸国
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • アジア太平洋地域のその他諸国
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • 中東とアフリカのその他諸国
• 中南米
  • ブラジル
  • アルゼンチン
  • 中南米のその他諸国

第13章 業界情勢

• ドナー血液成分市場における成長戦略
• 有機的成長戦略
• 無機的成長戦略

第14章 企業プロファイル

• Roswell Park Comprehensive Cancer Center
• Policlinico of Milan
• Vitalant
• MD Anderson Cancer Center.
• The Johns Hopkins Hospital
• The Royal Marsden
• Gustave Roussy
• Peter MacCallum Cancer Centre
• Tata Memorial Hospital
• Memorial Sloan Kettering Cancer Center

第15章 付録

List Of Tables

• Table 1. Donor Blood Component Market Segmentation
• Table 2. Average Selling Price Per Unit (US$) of Blood Components, 2024
• Table 3. Global Disease Prevalence of 5 Key Diseases, 2024
• Table 4. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 5. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 6. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
• Table 7. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
• Table 8. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 9. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 10. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 11. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 12. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 13. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 14. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 15. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 16. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 17. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 18. North America: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 19. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 20. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 21. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 22. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 23. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 24. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 25. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 26. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 27. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 28. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 29. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 30. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 31. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 32. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 33. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 34. United States: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 35. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 36. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 37. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 38. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 39. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 40. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 41. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 42. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 43. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 44. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 45. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 46. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 47. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 48. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 49. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 50. Canada: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 51. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 52. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 53. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 54. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 55. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 56. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 57. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 58. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 59. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 60. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 61. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 62. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 63. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 64. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 65. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 66. Mexico: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 67. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 68. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 69. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 70. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 71. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 72. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 73. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 74. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 75. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 76. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 77. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 78. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 79. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 80. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 81. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 82. Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 83. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 84. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 85. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 86. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 87. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 88. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 89. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 90. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 91. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 92. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 93. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 94. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 95. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 96. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 97. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 98. Germany: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 99. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 100. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 101. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 102. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 103. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 104. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 105. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 106. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 107. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 108. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 109. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 110. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 111. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 112. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 113. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 114. United Kingdom: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 115. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 116. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 117. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 118. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 119. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 120. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 121. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 122. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 123. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 124. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 125. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 126. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 127. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 128. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 129. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 130. France: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 131. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 132. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 133. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 134. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 135. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 136. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 137. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 138. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 139. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 140. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 141. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 142. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 143. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 144. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 145. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 146. Spain: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 147. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 148. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 149. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 150. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 151. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 152. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 153. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 154. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 155. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 156. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 157. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 158. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 159. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 160. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 161. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 162. Italy: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 163. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 164. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 165. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 166. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 167. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 168. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 169. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 170. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 171. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 172. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 173. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 174. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 175. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 176. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 177. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 178. Rest of Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 179. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 180. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 181. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 182. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 183. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 184. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 185. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 186. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 187. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 188. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 189. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 190. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 191. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 192. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 193. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 194. Asia Pacific: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 195. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 196. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 197. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 198. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 199. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 200. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 201. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 202. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 203. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 204. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 205. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 206. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 207. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 208. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 209. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 210. China: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 211. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 212. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 213. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 214. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 215. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 216. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 217. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 218. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 219. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 220. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 221. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 222. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 223. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 224. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 225. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 226. Japan: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 227. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 228. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 229. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 230. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 231. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 232. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 233. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 234. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 235. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 236. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 237. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 238. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 239. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 240. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 241. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 242. India: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 243. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 244. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 245. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 246. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 247. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 248. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 249. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 250. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 251. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 252. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 253. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 254. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 255. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 256. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 257. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 258. Australia: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 259. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 260. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 261. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 262. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 263. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 264. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 265. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 266. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 267. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 268. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 269. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 270. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 271. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 272. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 273. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 274. South Korea: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 275. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 276. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 277. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 278. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 279. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 280. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 281. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 282. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 283. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 284. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 285. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 286. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 287. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 288. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 289. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 290. Rest of APAC: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 291. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 292. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
• Table 293. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
• Table 294. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
• Table 295. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
• Table 296. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
• Table 297. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
• Table 298. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
• Table 299. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
• Table 300. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
• Table 301. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
• Table 302. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
• Table 303. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
• Table 304. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
• Table 305. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
• Table 306. Middle East and Africa: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
• Table 307. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component

Table

List Of Figures

• Figure 1. Donor Blood Component Market Segmentation, by Geography
• Figure 2. PEST Analysis
• Figure 3. Impact Analysis of Drivers and Restraints
• Figure 4. Donor Blood Component Market Revenue (US$ Million), 2021-2031
• Figure 5. Donor Blood Component Market Share (%) - by Blood Component (2024 and 2031)
• Figure 6. Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 7. White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 8. Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 9. Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 10. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 11. Donor Blood Component Market Share (%) - by Indication (2024 and 2031)
• Figure 12. Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 13. Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 14. Donor Blood Component Market Share (%) - by Application (2024 and 2031)
• Figure 15. Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 16. Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 17. Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 18. Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 19. Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 20. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 21. Donor Blood Component Market Share (%) - by Age Group (2024 and 2031)
• Figure 22. Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 23. Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 24. Donor Blood Component Market Share (%) - by End User (2024 and 2031)
• Figure 25. Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 26. Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 27. Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 28. Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 29. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 30. North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
• Figure 31. North America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
• Figure 32. United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 33. Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 34. Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 35. Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
• Figure 36. Europe: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
• Figure 37. Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 38. United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 39. France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 40. Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 41. Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 42. Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 43. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
• Figure 44. Asia Pacific: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
• Figure 45. China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 46. Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 47. India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 48. Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 49. South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 50. Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 51. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
• Figure 52. Middle East and Africa: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
• Figure 53. Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 54. South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 55. United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 56. Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 57. South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
• Figure 58. South and Central America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
• Figure 59. Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 60. Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 61. Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
• Figure 62. Growth Strategies in the Donor Blood Component Market

According to our new research study on "Donor Blood Component Market Forecast to 2031 -Global Analysis - by Blood Component, Indication, Application, Age Group, and Geography," the market is anticipated to grow from US$ 10.08 billion in 2024 and is projected to reach US$ 14.64 billion by 2031; it is expected to register a CAGR of 5.7% during 2025-2031. Rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness are contributing to the growing donor blood component market size. However, the inconsistent voluntary donations hamper the donor blood component market growth. Further, rising demand for plasma-derived therapies are expected to bring in new donor blood component market trends in the coming years.

The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies. However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.

Donor Blood Component Market Analysis

Emerging Market Demand to Provide Market Opportunities in Future

Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public-private alliances that have had on national blood systems. Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.

According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.

The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.

Donor Blood Component Market Report Segmentation Analysis

Key segments that contributed to the derivation of the donor blood component market analysis are Blood Component, Indication, application, age group, gender, and end user.

Based on blood component, the donor blood components market is segmented into red blood cells, white blood cells, platelets, plasma, and others. The red blood cells segment held the largest share of the market in 2024.

By indication, the donor blood components market is bifurcated into immunosuppression and oncology. The immunosuppression segment dominated the market in 2024.

In terms of application, the donor blood components market is segmented into anemia management, thrombocytopenia treatment, coagulopathy correction, supportive care during chemotherapy, surgery, and others. The anemia management segment held the largest share of the market in 2024.

By age group, the donor blood components market is bifurcated into adult and child. The adult segment dominated the market in 2024.

As per end user, the donor blood components market is categorized into hospitals, oncology centers, transplant centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2024.

Donor Blood Component Market: Competitive Landscape and Key Developments

Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key companies operating in the donor blood component market.

The World Health Organization (WHO), the American Society of Plastic Surgeons, Health Resources and Services Administration, American Cancer Society, The Leukemia & Lymphoma Society, Health Canada, International Agency for Research on Cancer (IARC), Federal Statistical Office (Destatis), Macmillan Cancer Support data, National Health Commission (NHC), Indian Council of Medical Research-National Centre for Disease Informatics and Research (ICMR-NCDIR), Australian Institute of Health and Welfare, Australian Red Cross Lifeblood, GLOBOCAN are among the primary and secondary sources referred to while preparing the donor blood components market report.

Table Of Contents

1. Introduction

• 1.1 Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Analyst Market Outlook

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:
• 3.3 Assumptions and Limitations

4. Donor Blood Component Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
• 4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
• 4.4 Global Disease Prevalence of 5 Key Diseases, 2024

5. Donor Blood Component Market - Key Market Dynamics

• 5.1 Donor Blood Component Market - Key Market Dynamics
• 5.2 Market Drivers
  • 5.2.1 Rising Prevalence of Cancer and Immunosuppressive Diseases
  • 5.2.2 Increasing Donor Awareness
• 5.3 Market Restraints
  • 5.3.1 Inconsistent Voluntary Donations
• 5.4 Market Opportunities
  • 5.4.1 Emerging Market Demand
• 5.5 Future Trends
  • 5.5.1 Rising Demand for Plasma-Derived Therapies
• 5.6 Impact of Drivers and Restraints:

6. Donor Blood Component Market - Global Market Analysis

• 6.1 Donor Blood Component Market Revenue (US$ Million), 2021-2031
• 6.2 Donor Blood Component Market Forecast Analysis

7. Donor Blood Component Market Analysis - by Blood Component

• 7.1 Red Blood Cells
  • 7.1.1 Overview
  • 7.1.2 Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 7.2 White blood cells
  • 7.2.1 Overview
  • 7.2.2 White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 7.3 Platelets
  • 7.3.1 Overview
  • 7.3.2 Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 7.4 Plasma
  • 7.4.1 Overview
  • 7.4.2 Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 7.5 Others
  • 7.5.1 Overview
  • 7.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

8. Donor Blood Component Market Analysis - by Indication

• 8.1 Immunosuppression
  • 8.1.1 Overview
  • 8.1.2 Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 8.2 Oncology
  • 8.2.1 Overview
  • 8.2.2 Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

9. Donor Blood Component Market Analysis - by Application

• 9.1 Anemia management
  • 9.1.1 Overview
  • 9.1.2 Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 9.2 Thrombocytopenia treatment
  • 9.2.1 Overview
  • 9.2.2 Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 9.3 Coagulopathy Correction
  • 9.3.1 Overview
  • 9.3.2 Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 9.4 Supportive care during chemotherapy
  • 9.4.1 Overview
  • 9.4.2 Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 9.5 Surgery
  • 9.5.1 Overview
  • 9.5.2 Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

10. Donor Blood Component Market Analysis - by Age Group

• 10.1 Adult
  • 10.1.1 Overview
  • 10.1.2 Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 10.2 Child
  • 10.2.1 Overview
  • 10.2.2 Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

11. Donor Blood Component Market Analysis - by End User

• 11.1 Hospitals
  • 11.1.1 Overview
  • 11.1.2 Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 11.2 Oncology centers
  • 11.2.1 Overview
  • 11.2.2 Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 11.3 Transplant centers
  • 11.3.1 Overview
  • 11.3.2 Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 11.4 Ambulatory surgical centers
  • 11.4.1 Overview
  • 11.4.2 Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
• 11.5 Others
  • 11.5.1 Overview
  • 11.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

12. Donor Blood Component Market - Geographical Analysis

• 12.1 North America
  • 12.1.1 North America Donor Blood Component Market Overview
  • 12.1.2 North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
    • 12.1.2.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
    • 12.1.2.2 North America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
    • 12.1.2.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
      • 12.1.2.3.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
      • 12.1.2.3.2 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
    • 12.1.2.4 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
    • 12.1.2.5 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
    • 12.1.2.6 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
  • 12.1.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
    • 12.1.3.1 United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.1.3.1.1 United States: Donor Blood Component Market Breakdown, by Blood Component
      • 12.1.3.1.2 United States: Donor Blood Component Market Breakdown, by Blood Component
      • 12.1.3.1.3 United States: Donor Blood Component Market Breakdown, by Indication
        • 12.1.3.1.3.1 United States: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.1.3.1.3.2 United States: Donor Blood Component Market Breakdown, by Oncology
      • 12.1.3.1.4 United States: Donor Blood Component Market Breakdown, by Application
      • 12.1.3.1.5 United States: Donor Blood Component Market Breakdown, by Age Group
      • 12.1.3.1.6 United States: Donor Blood Component Market Breakdown, by End User
    • 12.1.3.2 Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.1.3.2.1 Canada: Donor Blood Component Market Breakdown, by Blood Component
      • 12.1.3.2.2 Canada: Donor Blood Component Market Breakdown, by Blood Component
      • 12.1.3.2.3 Canada: Donor Blood Component Market Breakdown, by Indication
        • 12.1.3.2.3.1 Canada: Donor Blood Component Market Breakdown,
        • 12.1.3.2.3.2 Canada: Donor Blood Component Market Breakdown, by Oncology
      • 12.1.3.2.4 Canada: Donor Blood Component Market Breakdown, by Application
      • 12.1.3.2.5 Canada: Donor Blood Component Market Breakdown, by Age Group
      • 12.1.3.2.6 Canada: Donor Blood Component Market Breakdown, by End User
    • 12.1.3.3 Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.1.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Blood Component
      • 12.1.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Blood Component
      • 12.1.3.3.3 Mexico: Donor Blood Component Market Breakdown, by Indication
        • 12.1.3.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.1.3.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Oncology
      • 12.1.3.3.4 Mexico: Donor Blood Component Market Breakdown, by Application
      • 12.1.3.3.5 Mexico: Donor Blood Component Market Breakdown, by Age Group
      • 12.1.3.3.6 Mexico: Donor Blood Component Market Breakdown, by End User
• 12.2 Europe
  • 12.2.1 Europe Donor Blood Component Market Overview
  • 12.2.2 Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
    • 12.2.2.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
    • 12.2.2.2 Europe: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
    • 12.2.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
      • 12.2.2.3.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
      • 12.2.2.3.2 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
    • 12.2.2.4 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
    • 12.2.2.5 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
    • 12.2.2.6 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
  • 12.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
    • 12.2.3.1 Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.2.3.1.1 Germany: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.1.2 Germany: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.1.3 Germany: Donor Blood Component Market Breakdown, by Indication
        • 12.2.3.1.3.1 Germany: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.2.3.1.3.2 Germany: Donor Blood Component Market Breakdown, by Oncology
      • 12.2.3.1.4 Germany: Donor Blood Component Market Breakdown, by Application
      • 12.2.3.1.5 Germany: Donor Blood Component Market Breakdown, by Age Group
      • 12.2.3.1.6 Germany: Donor Blood Component Market Breakdown, by End User
    • 12.2.3.2 United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.2.3.2.1 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.2.2 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.2.3 United Kingdom: Donor Blood Component Market Breakdown, by Indication
        • 12.2.3.2.3.1 United Kingdom: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.2.3.2.3.2 United Kingdom: Donor Blood Component Market Breakdown, by Oncology
      • 12.2.3.2.4 United Kingdom: Donor Blood Component Market Breakdown, by Application
      • 12.2.3.2.5 United Kingdom: Donor Blood Component Market Breakdown, by Age Group
      • 12.2.3.2.6 United Kingdom: Donor Blood Component Market Breakdown, by End User
    • 12.2.3.3 France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.2.3.3.1 France: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.3.2 France: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.3.3 France: Donor Blood Component Market Breakdown, by Indication
        • 12.2.3.3.3.1 France: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.2.3.3.3.2 France: Donor Blood Component Market Breakdown, by Oncology
      • 12.2.3.3.4 France: Donor Blood Component Market Breakdown, by Application
      • 12.2.3.3.5 France: Donor Blood Component Market Breakdown, by Age Group
      • 12.2.3.3.6 France: Donor Blood Component Market Breakdown, by End User
    • 12.2.3.4 Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.2.3.4.1 Spain: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.4.2 Spain: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.4.3 Spain: Donor Blood Component Market Breakdown, by Indication
        • 12.2.3.4.3.1 Spain: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.2.3.4.3.2 Spain: Donor Blood Component Market Breakdown, by Oncology
      • 12.2.3.4.4 Spain: Donor Blood Component Market Breakdown, by Application
      • 12.2.3.4.5 Spain: Donor Blood Component Market Breakdown, by Age Group
      • 12.2.3.4.6 Spain: Donor Blood Component Market Breakdown, by End User
    • 12.2.3.5 Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.2.3.5.1 Italy: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.5.2 Italy: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.5.3 Italy: Donor Blood Component Market Breakdown, by Indication
        • 12.2.3.5.3.1 Italy: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.2.3.5.3.2 Italy: Donor Blood Component Market Breakdown, by Oncology
      • 12.2.3.5.4 Italy: Donor Blood Component Market Breakdown, by Application
      • 12.2.3.5.5 Italy: Donor Blood Component Market Breakdown, by Age Group
      • 12.2.3.5.6 Italy: Donor Blood Component Market Breakdown, by End User
    • 12.2.3.6 Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.2.3.6.1 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.6.2 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
      • 12.2.3.6.3 Rest of Europe: Donor Blood Component Market Breakdown, by Indication
        • 12.2.3.6.3.1 Rest of Europe: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.2.3.6.3.2 Rest of Europe: Donor Blood Component Market Breakdown, by Oncology
      • 12.2.3.6.4 Rest of Europe: Donor Blood Component Market Breakdown, by Application
      • 12.2.3.6.5 Rest of Europe: Donor Blood Component Market Breakdown, by Age Group
      • 12.2.3.6.6 Rest of Europe: Donor Blood Component Market Breakdown, by End User
• 12.3 Asia Pacific
  • 12.3.1 Asia Pacific Donor Blood Component Market Overview
  • 12.3.2 Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
    • 12.3.2.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
    • 12.3.2.2 Asia Pacific: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
    • 12.3.2.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
      • 12.3.2.3.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
      • 12.3.2.3.2 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
    • 12.3.2.4 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
    • 12.3.2.5 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
    • 12.3.2.6 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
  • 12.3.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
    • 12.3.3.1 China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.3.3.1.1 China: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.1.2 China: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.1.3 China: Donor Blood Component Market Breakdown, by Indication
        • 12.3.3.1.3.1 China: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.3.3.1.3.2 China: Donor Blood Component Market Breakdown, by Oncology
      • 12.3.3.1.4 China: Donor Blood Component Market Breakdown, by Application
      • 12.3.3.1.5 China: Donor Blood Component Market Breakdown, by Age Group
      • 12.3.3.1.6 China: Donor Blood Component Market Breakdown, by End User
    • 12.3.3.2 Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.3.3.2.1 Japan: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.2.2 Japan: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.2.3 Japan: Donor Blood Component Market Breakdown, by Indication
        • 12.3.3.2.3.1 Japan: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.3.3.2.3.2 Japan: Donor Blood Component Market Breakdown, by Oncology
      • 12.3.3.2.4 Japan: Donor Blood Component Market Breakdown, by Application
      • 12.3.3.2.5 Japan: Donor Blood Component Market Breakdown, by Age Group
      • 12.3.3.2.6 Japan: Donor Blood Component Market Breakdown, by End User
    • 12.3.3.3 India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.3.3.3.1 India: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.3.2 India: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.3.3 India: Donor Blood Component Market Breakdown, by Indication
        • 12.3.3.3.3.1 India: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.3.3.3.3.2 India: Donor Blood Component Market Breakdown, by Oncology
      • 12.3.3.3.4 India: Donor Blood Component Market Breakdown, by Application
      • 12.3.3.3.5 India: Donor Blood Component Market Breakdown, by Age Group
      • 12.3.3.3.6 India: Donor Blood Component Market Breakdown, by End User
    • 12.3.3.4 Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.3.3.4.1 Australia: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.4.2 Australia: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.4.3 Australia: Donor Blood Component Market Breakdown, by Indication
        • 12.3.3.4.3.1 Australia: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.3.3.4.3.2 Australia: Donor Blood Component Market Breakdown, by Oncology
      • 12.3.3.4.4 Australia: Donor Blood Component Market Breakdown, by Application
      • 12.3.3.4.5 Australia: Donor Blood Component Market Breakdown, by Age Group
      • 12.3.3.4.6 Australia: Donor Blood Component Market Breakdown, by End User
    • 12.3.3.5 South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.3.3.5.1 South Korea: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.5.2 South Korea: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.5.3 South Korea: Donor Blood Component Market Breakdown, by Indication
        • 12.3.3.5.3.1 South Korea: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.3.3.5.3.2 South Korea: Donor Blood Component Market Breakdown, by Oncology
      • 12.3.3.5.4 South Korea: Donor Blood Component Market Breakdown, by Application
      • 12.3.3.5.5 South Korea: Donor Blood Component Market Breakdown, by Age Group
      • 12.3.3.5.6 South Korea: Donor Blood Component Market Breakdown, by End User
    • 12.3.3.6 Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.3.3.6.1 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.6.2 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
      • 12.3.3.6.3 Rest of APAC: Donor Blood Component Market Breakdown, by Indication
        • 12.3.3.6.3.1 Rest of APAC: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.3.3.6.3.2 Rest of APAC: Donor Blood Component Market Breakdown, by Oncology
      • 12.3.3.6.4 Rest of APAC: Donor Blood Component Market Breakdown, by Application
      • 12.3.3.6.5 Rest of APAC: Donor Blood Component Market Breakdown, by Age Group
      • 12.3.3.6.6 Rest of APAC: Donor Blood Component Market Breakdown, by End User
• 12.4 Middle East and Africa
  • 12.4.1 Middle East and Africa Donor Blood Component Market Overview
  • 12.4.2 Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
    • 12.4.2.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
    • 12.4.2.2 Middle East and Africa: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
    • 12.4.2.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
      • 12.4.2.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
      • 12.4.2.3.2 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
    • 12.4.2.4 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
    • 12.4.2.5 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
    • 12.4.2.6 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
  • 12.4.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
    • 12.4.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
    • 12.4.3.2 Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.4.3.2.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.2.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.2.3 Saudi Arabia: Donor Blood Component Market Breakdown, by Indication
        • 12.4.3.2.3.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.4.3.2.3.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Oncology
      • 12.4.3.2.4 Saudi Arabia: Donor Blood Component Market Breakdown, by Application
      • 12.4.3.2.5 Saudi Arabia: Donor Blood Component Market Breakdown, by Age Group
      • 12.4.3.2.6 Saudi Arabia: Donor Blood Component Market Breakdown, by End User
    • 12.4.3.3 South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.4.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.3.3 South Africa: Donor Blood Component Market Breakdown, by Indication
        • 12.4.3.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.4.3.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Oncology
      • 12.4.3.3.4 South Africa: Donor Blood Component Market Breakdown, by Application
      • 12.4.3.3.5 South Africa: Donor Blood Component Market Breakdown, by Age Group
      • 12.4.3.3.6 South Africa: Donor Blood Component Market Breakdown, by End User
    • 12.4.3.4 United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.4.3.4.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.4.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.4.3 United Arab Emirates: Donor Blood Component Market Breakdown, by Indication
        • 12.4.3.4.3.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.4.3.4.3.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Oncology
      • 12.4.3.4.4 United Arab Emirates: Donor Blood Component Market Breakdown, by Application
      • 12.4.3.4.5 United Arab Emirates: Donor Blood Component Market Breakdown, by Age Group
      • 12.4.3.4.6 United Arab Emirates: Donor Blood Component Market Breakdown, by End User
    • 12.4.3.5 Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.4.3.5.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.5.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
      • 12.4.3.5.3 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Indication
        • 12.4.3.5.3.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.4.3.5.3.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Oncology
      • 12.4.3.5.4 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Application
      • 12.4.3.5.5 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Age Group
      • 12.4.3.5.6 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by End User
• 12.5 South and Central America
  • 12.5.1 South and Central America Donor Blood Component Market Overview
  • 12.5.2 South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
    • 12.5.2.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
    • 12.5.2.2 South and Central America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
    • 12.5.2.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
      • 12.5.2.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
      • 12.5.2.3.2 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
    • 12.5.2.4 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
    • 12.5.2.5 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
    • 12.5.2.6 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
  • 12.5.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
    • 12.5.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
    • 12.5.3.2 Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.5.3.2.1 Brazil: Donor Blood Component Market Breakdown, by Blood Component
      • 12.5.3.2.2 Brazil: Donor Blood Component Market Breakdown, by Blood Component
      • 12.5.3.2.3 Brazil: Donor Blood Component Market Breakdown, by Indication
        • 12.5.3.2.3.1 Brazil: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.5.3.2.3.2 Brazil: Donor Blood Component Market Breakdown, by Oncology
      • 12.5.3.2.4 Brazil: Donor Blood Component Market Breakdown, by Application
      • 12.5.3.2.5 Brazil: Donor Blood Component Market Breakdown, by Age Group
      • 12.5.3.2.6 Brazil: Donor Blood Component Market Breakdown, by End User
    • 12.5.3.3 Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.5.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Blood Component
      • 12.5.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Blood Component
      • 12.5.3.3.3 Argentina: Donor Blood Component Market Breakdown, by Indication
        • 12.5.3.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.5.3.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Oncology
      • 12.5.3.3.4 Argentina: Donor Blood Component Market Breakdown, by Application
      • 12.5.3.3.5 Argentina: Donor Blood Component Market Breakdown, by Age Group
      • 12.5.3.3.6 Argentina: Donor Blood Component Market Breakdown, by End User
    • 12.5.3.4 Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 12.5.3.4.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
      • 12.5.3.4.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
      • 12.5.3.4.3 Rest of South and Central America: Donor Blood Component Market Breakdown, by Indication
        • 12.5.3.4.3.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Immunosuppression
        • 12.5.3.4.3.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Oncology
      • 12.5.3.4.4 Rest of South and Central America: Donor Blood Component Market Breakdown, by Application
      • 12.5.3.4.5 Rest of South and Central America: Donor Blood Component Market Breakdown, by Age Group
      • 12.5.3.4.6 Rest of South and Central America: Donor Blood Component Market Breakdown, by End User

13. Industry Landscape

• 13.1 Overview
• 13.2 Growth Strategies in the Donor Blood Component Market
• 13.3 Organic Growth Strategies
  • 13.3.1 Overview
• 13.4 Inorganic Growth Strategies
  • 13.4.1 Overview

14. COMPANY PROFILES

• 14.1 Roswell Park Comprehensive Cancer Center
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
• 14.2 Policlinico of Milan
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
• 14.3 Vitalant
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
• 14.4 MD Anderson Cancer Center.
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
• 14.5 The Johns Hopkins Hospital
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
• 14.6 The Royal Marsden
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
• 14.7 Gustave Roussy
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
• 14.8 Peter MacCallum Cancer Centre
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
• 14.9 Tata Memorial Hospital
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
• 14.10 Memorial Sloan Kettering Cancer Center
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis

15. Appendix

• 15.1 About The Insight Partners
• 15.2 Glossary of Terms